Furthermore, the statistical data based on 40,853 individuals with NDDs and the subsequent functional evidence supported that de novo mutations (DNMs) in the essential SG genes, such as G3BP1, G3BP2, and CAPRIN1, are associated with NDD risk. Here, G3BP2 is linked to Neurodevelopmental delay.